课题基金 / 基金详情

Mechanisms of endogenous cannabinoid mediated analgesia within the midbrain

Mechanisms of endogenous cannabinoid mediated analgesia within the midbrain
内源性大麻素介导的中脑镇痛机制
批准号:
nhmrc : 457563
负责人:
Dr Christopher Vaughan
金额:
$34.59万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

Dr Christopher Vaughan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
While opioid analgesics such as morphine are the most important drugs used to treat moderate to severe pain, their usefulness is limited by side effects such as tolerance and respiratory depression. In addition, clinically relevant neuropathic chronic pain syndromes (caused by nervous system damage) are relatively resistant to opioids. Animal studies have shown that the active ingredient of the plant Cannabis sativa, THC, and a number of synthetic cannabinoids are analgesic in acute pain models, and interestingly, in chronic neuropathic pain models. Unfortunately, cannabinoid also produce a spectrum of adverse side-effects. Administered cannabinoids such as THC produce their physiological effects by mimicking the actions of the body's own cannabinoids (endocannabinoids) by activating cell-surface proteins, called cannabinoid receptors. The endocannabinoid neurotransmitter system is emerging as a potential therapeutic target. For example, it has recently been shown that analgesia induced by physiological stressors is partly mediated by endocannabinoids within the brain. In addition, novel endocannabinoid breakdown inhibitors have some efficacy in animal models of anxiety and chronic pain. Several brain regions are known to play a pivotal role in the analgesic actions of exogenous and endogenous cannabinoids. In previous studies I have identified the cellular mechanisms by which exogenously applied opioids and cannabinoids produce their analgesic effects in single brain cells. However, the mechanisms of endocannabinoid actions within these brain regions are unknown. The proposed study will determine the cellular actions of endogenously released cannabinoids in normal animals and in chronic pain states. Parallel studies will examine the effect of modulation of the endocannabinoid system in animal models of pain. These techniques have the potential to identify novel endocannabinoid analgesic pharmacotherapies with enhanced efficacy and reduced side effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chronic pain and calcium permeable AMPA receptors
  • 批准号:
    nhmrc : 1083569
  • 项目类别:
    Project Grants
  • 资助金额:
    $38.48万
  • 财政年份:
    2015
  • 负责人:
    Dr Christopher Vaughan
  • 依托单位:
Molecular targets of amino acid/neurotransmitter conjugates of fatty acids
  • 批准号:
    nhmrc : 1002680
  • 项目类别:
    Project Grants
  • 资助金额:
    $56.44万
  • 财政年份:
    2011
  • 负责人:
    Dr Christopher Vaughan
  • 依托单位:
Endocannabinoid-TRP interactions in midbrain analgesic pathways
  • 批准号:
    nhmrc : 1003097
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.13万
  • 财政年份:
    2011
  • 负责人:
    Dr Christopher Vaughan
  • 依托单位:
Mechanisms of serotonergic and triptan mediated analgesia within the midbrain
  • 批准号:
    nhmrc : 632546
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $36.47万
  • 财政年份:
    2010
  • 负责人:
    Dr Christopher Vaughan
  • 依托单位:
国内基金
海外基金
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
淫羊藿苷拮抗内源性甲醛神经毒性的作用及机制研究
  • 批准号:
    81102683
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    黎巍威
  • 依托单位: